🇺🇸 FDA
Company

Structure

Structure Therapeutics

GPCR pharma USA

Quick answer

Structure is a pharma company (GPCR) headquartered in SOUTH SAN FRANCISCO, CA, USA with 12 tracked pipeline programs.

Pipeline (12)

project

Aleniglipron

Obese

Phase 2 · small_molecule · active

1 trials project

Aleniglipron or Placebo

Obesity, Overweight, or Chronic Weight Management

Phase 2 · small_molecule · active

2 trials project

GPC-100

Multiple Myeloma

Phase 2 · small_molecule · completed

1 trials project

GSBR-1290

Overweight or Obesity

Phase 2 · small_molecule · completed

1 trials project

TG-0054

Multiple Myeloma

Phase 2 · small_molecule · completed

1 trials project

TG-0054 (2.24 mg/kg)

Multiple Myeloma

Phase 2 · small_molecule · completed

1 trials project

TG-0054 combined with G-CSF

Multiple Myeloma

Phase 2 · small_molecule · completed

1 trials project

aleniglipron or placebo

Obesity

Phase 2 · small_molecule · completed

1 trials project

GSBR-1290

Healthy Volunteers

Phase 1 · small_molecule · completed

1 trials project

GSBR-1290 (Capsule/Tablet)

Healthy Volunteers

Phase 1 · small_molecule · active

1 trials project

TG-0054

Healthy

Phase 1 · small_molecule · completed

1 trials project

carotid-femoral pulse-wave velocity

Covid19

Unknown · other · active

1 trials

Patents (8)

patent

US 12279630

Treatment and prevention of seed allergies

Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12251417

Antimicrobial compounds from the genus Delftia

Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12139522

T-cells comprising two different chimeric antigen receptors and uses thereof

Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12134650

Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer

Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12084350

Allotrope of carbon having increased electron delocalization

Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12023348

EGR1 targeting molecules for the treatment of inflammatory and hyperproliferativ

Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11944644

T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses

Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11932871

Methods of culturing t cells and uses of same

Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)